• Image
  • Image
  • Image
  • Image

Submit Abstract to VB2017

Vascular Biology 2017

Developmental Vascular Biology and Genetics Workshop VII 
and 
Vascular Matrix Biology and Bioengineering Workshop VI

October 15-19, 2017

Asilomar Conference Grounds on the Monterey Peninsula

No longer accepting abstracts 

However, we are currently accepting submissions for Nano-Talks!

Call for Nano-Talks
Nano-talks are five minute presentations that feature only five slides. The session will be presented on Monday, October 16 from 4:30-5:00pm at Vascular Biology 2017.

If you have a great experiment or data that sheds light on a little understood area or illuminates a controversial area, AND it can be shown in 5 slides and 5 minutes, please consider participating in this session. This will be an exciting and fun opportunity to increase the exchange of ideas and concepts at VB2017!

To be selected to give a Nano-Talk: 1) Register to attend VB2017, 2) Send your name, affiliation and presentation title to This email address is being protected from spambots. You need JavaScript enabled to view it. and 3) include a five-slide pdf of your presentation. This pdf does not have to be the final version but we want to make sure you can present your "story" in 5 slides/5 minutes. 

Presenters will be selected by a review committee. We will accept no more than five presentations for this session and submissions must be received by September 15.


Please follow the application rules included in the abstract submission guidelines for late-breaking abstracts.

You may submit more than one abstract, however, the same abstract may not be submitted to both workshops.

The organizers will attempt to program all submitted abstracts. NAVBO reserves the right to reject any
abstract. Authors should indicate their preference for either poster or oral presentation, however, due to the limited number of slots within oral sessions, most abstracts will be programmed for poster presentation.

  • Use Arial font, 10 point
  • Abstract titles are limited to 200 characters (including spaces)
  • Abstracts are limited to 1,750 characters (including spaces)
  • DO NOT include the title, authors or author affiliations in the body of the abstract
  • Enter each co-author into the database, be consistent with affiliations and include co-authors' emails, cities, states and countries
  • Additional instructions available here.

For Junior Faculty

If you are within five years of your first independent investigator position and are submitting an abstract to Vascular Biology, consider applying for the Springer Junior Investigator Award.  See here for details and criteria.


Topic Categories:

Developmental Vascular Biology and Genetics:
Coronary Vascular Development
Lymphatic Development
Organ-Specific Vasculature
Transcriptional Control
Vascular Cell Biology
Vascular Progenitors
Vascular Signaling

Vascular Matrix Biology and Bioengineering:
Engineering Angiogenesis
Extracellular Matrix and Disease
Mechanotransduction
Vascular Calcification
Vascular Imaging
Vascular Mechanics
Vascular Tissue Engineering

Vascular Therapeutics
Bioengineering Organ-Specific Vasculatures
Engineering Vascular Morphogenesis

Vascular Biology (poster presentations only):
Animal Models of Vascular Diseases
Atherosclerosis and Restenosis
Hypertension/Endothelial-dependent Responses
Lipid Mediators and Lipoproteins
Regulation of Epithelial and Endothelial Junctions
Stem Cells in Vascular Biology
Vascular Inflammation
Vascular Smooth Muscle Cell Biology
Other Bioengineering
Other Developmental Biology
Other Genetics (including HHT)
Other Matrix Biology
Other

 

Submit your abstract here

Users of Internet Explorer, please take note of the compatibility issue.

compatibilityicon

Strategic Partners:

Event Partner:

Contributor:

Funding for this conference was made possible (in part) by 1R13HL137350-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.